Comparison of two lotions for acne vulgaris
Bourne, M.S.
Practitioner 223(1334): 274-276
1979
ISSN/ISBN: 0032-6518 PMID: 159439 Document Number: 144650
Document emailed within 1 workday
Related Documents
Balambal, R.; Thiruvengadam, K.V.; Kameswarant, L.; Janaki, V.R.; Thambiah, A.S. 1985: Ocimum basilicum in acne vulgaris--a controlled comparison with a standard regime Journal of the Association of Physicians of India 33(8): 507-508Dhawan, S.S. 2009: Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris Cutis 83(5): 265-272
Stoughton, R.B.; Cornell, R.C.; Gange, R.W.; Walter, J.F. 1980: Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris Cutis 26(4): 424-425; 429
Tanghetti, E.; Dhawan, S.; Green, L.; Del Rosso, J.; Draelos, Z.; Leyden, J.; Shalita, A.; Glaser, D.A.; Grimes, P.; Webster, G.; Barnett, P.; Le Gall, N. 2010: Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris Journal of Drugs in Dermatology: Jdd 9(5): 549-558
Mazurkiewicz, W.; Kostanecki, W.; Blaszczyk, M.; Dabrowska, H. 1974: Treatment of some diseases involving keratinization such as acne vulgaris and acne phlegmonosa with vitamin a acid Przeglad Dermatologiczny 61(1): 61-64
Webster, G.F.; Guenther, L.; Poulin, Y.P.; Solomon, B.A.; Loven, K.; Lee, J. 2002: A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris Cutis 69(2 Suppl): 4-11
Gold, M.H.; Rao, J.; Goldman, M.P.; Bridges, T.M.; Bradshaw, V.L.; Boring, M.M.; Guider, A.N. 2005: A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution Journal of Drugs in Dermatology: Jdd 4(1): 64-70
Tanghetti, E.; Dhawan, S.; Green, L.; Ling, M.; Downie, J.; Germain, M.A.; Kasteler, J.S.; Kircik, L.; Oefelein, M.G.; Draelos, Z. 2011: Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris Journal of Drugs in Dermatology: Jdd 10(7): 783-792
Kircik, L.H.; Dahl, A.; Yatskayer, M.; Raab, S.; Oresajo, C. 2012: Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris Journal of Drugs in Dermatology: Jdd 11(6): 737-740
Jemec, G.B.E.; Linneberg, A.; Nielsen, N.Henrik.; Frølund, L.; Madsen, F.; Jørgensen, T. 2002: Have oral contraceptives reduced the prevalence of acne? a population-based study of acne vulgaris, tobacco smoking and oral contraceptives Dermatology 204(3): 179-184
Rabinowitz 1997: Acne Vulgaris Adolescent Medicine 8(1): 77-86
Turner, T.W. 1976: Acne vulgaris Medical Journal of Australia 1(18): 672-673
Polano, M.K. 1974: Acne vulgaris Nederlands Tijdschrift Voor Geneeskunde 118(3): 81-84
Schneider, W. 1973: Acne vulgaris Deutsche Medizinische Wochenschrift 98(32): 1511
Baumann, L.S.; Oresajo, C.; Yatskayer, M.; Dahl, A.; Figueras, K. 2013: Comparison of clindamycin 1% and benzoyl peroxide 5% gel to a novel composition containing salicylic acid, capryloyl salicylic acid, HEPES, glycolic acid, citric acid, and dioic acid in the treatment of acne vulgaris Journal of Drugs in Dermatology: Jdd 12(3): 266-269
Pace, B.F. 1976: Cystic acne vulgaris Cutis 18(2): 257-258
Quan, M.; Strick, R.A. 1988: Management of acne vulgaris American Family Physician 38(2): 207-218
Shapiro, S.C. 1984: Acne vulgaris in adolescence Arizona Medicine 41(2): 98-100
Skendzić, M.; Blagojević, D. 1981: Treatment of acne vulgaris Srpski Arhiv Za Celokupno Lekarstvo 109(8): 1049-1056
Murphy, G. 1999: Management of acne vulgaris Irish Medical Journal 92(5): 360-361